Impact BioMedical Inc. Share Price & Technical Analysis
IBO · $0.54 (+1.89%)
Healthcare / Biotechnology
$0.54
+1.89%
Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States. The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application i…
Price chart
Seasonality
May has 1 positive and 1 negative years (last 3 years shown)
-29% return in May, 25% avg return in past 3 year May month.
18% return in 2026, -56% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 0% | -20% | 50% | 17% | -29% | – | – | – | – | – | – | – | 18% |
| 25 | 13% | -24% | -40% | -71% | 25% | 20% | 0% | 0% | 17% | -17% | -20% | 25% | -73% |
| 24 | – | – | – | – | – | – | – | – | -33% | 10% | 32% | -48% | -40% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Weak
Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States. The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone. It also develops functional fragrance formulation, a suite of functional fragrances containing specialized botanical ingredients with application as an antimicrobial, and as an additive in insect repellents, detergents, lotions, shampoo, fabrics, and other substances. In addition, the company develops Equivir/Equivir G technology, a novel blend of polyphenols, which have demonstrated antiviral effects for use as health supplements and medications. Further, it is developing 3F (functional fragrance formulation), a formulation of botanical ingredients. Impact BioMedical Inc. was incorporated in 2018 and is based in Houston, Texas. Impact BioMedical Inc. operates as a subsidiary of DSS BioHealth Security, Inc
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$67.90M
P/E ratio
—
52W high
$1.95
52W low
$0.36
Volume
25,323
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Impact BioMedical Inc. share price today?
- Impact BioMedical Inc. (IBO) last traded around $0.54 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does IBO have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for IBO. Download the app for real-time alerts.
- How can I analyze Impact BioMedical Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.